Akros Pharma

Akros Pharma is a corporation based in Princeton, New Jersey. Established in 1999, the firm operates as a pharmaceutical development company and the US arm of JT Pharmaceuticals. It focuses on bringing innovative therapeutics from JT's Central Pharmaceutical Research Institute to the US and global markets through efficient clinical studies, patent strategy, licensing, and collaborative alliances. Its pipeline includes oral candidates targeting autoimmune disorders, type 2 diabetes, heart failure, neurodegenerative and pulmonary diseases, several in Phase 1 and Phase 2 trials. It also leverages strategic partnerships for licensing and co-development. The assets are managed by the executive team.